NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









MyMeds

MyMeds

Private
Minneapolis, MinnesotaHealthcare & Life Scienceshttps://my-meds.com/

Last Round

VC Round

Mar 10, 2020

Momentum

Top 25%

of companies Caplight tracks

Company Overview

MyMeds is a healthtech company that provides a digital medication management and analytics platform designed to improve medication adherence and support value-based care initiatives.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Patient Engagement, Data Integration, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Keywords

medication adherencevalue-based caremedication managementpharmacy benefit managerPBMmedication non-adherenceclinical analyticsMedicare Advantagepopulation healthdigital healthmedication adherence apphealthcare APIStar Ratingspatient engagementmedtechhealth tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MyMeds Comps

Public and private peers based on sector, stage, and business model.

MyMeds comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

MyMeds Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMar 10, 2020
AcceleratorSep 4, 2019
Convertible DebtAug 13, 2018

Key People

Founding team and executive leadership

Rajiv Shah

Founder And CEO

Founding Team

MyMeds Investors

Notable investors and investment history

MyMeds investors
InvestorRounds
Seae VenturesConvertible Debt
Artifact CapitalConvertible Debt
SAP.iO FoundryAccelerator, Convertible Debt
SAP.iOAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 16, 2026

    Monthly visitors grew 339% MoM, reaching 7K.

MyMeds Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MyMeds Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MyMeds's valuation, stock price, and market status.

Firmographic Details

HeadquartersMinneapolis, Minnesota
Employee Range14
Year Founded2013
Last FundingMar 10, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.